Predict your next investment

ImaCor company logo
HEALTHCARE | Medical Devices & Equipment / Patient Monitoring
imacorinc.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$5.5M

Last Raised

$5.5M | 13 yrs ago

About ImaCor

ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time, collectively serving patients, clinicians, and hospital administrators with the best possible clinical outcomes and cost-effective resource utilization. hTEE technology is enabled through the ZuraTM ultrasound systems and the miniaturized, disposable ClariTEE probe, uniquely designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. Direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time.

ImaCor Headquarter Location

839 Stewart Av

Garden City, New York, 11530,

United States

Latest ImaCor News

ImaCor Introduces AllInOne Hemodynamic Management Platform to Critical Care Community

Jan 13, 2015

Lightbeam Health Platform Enables Improved Patient Care at Lower Cost for Community Health Alliance ACO ImaCor, Inc. , the developer of the world’s only hemodynamic transesophageal echocardiography ( hTEE™ ) technology, will be showcasing Zura EVO1™, its all-in-one platform for advanced hemodynamic management at three annual scientific meetings this month: EAST (Eastern Association for the Surgery of Trauma), SCCM (Society of Critical Care Medicine), and STS (Society of Thoracic Surgeons). This marks the premier demonstration of the enhanced platform, a first-of-its-kind for hemodynamic management. The new capabilities are imaging features at 7 MHz and 18 cm depth, hemodynamic trending data of cardiac filling and function, and availability of a transthoracic echocardiography (TTE) probe for complementary hemodynamic management. EVO1 all-in-one hemodynamic management platform (Photo: Business Wire) ImaCor’s all-in-one hemodynamic management platform offers hTEE, which is enabled by a miniaturized, disposable probe that can be left indwelling for up to 72 hours of direct continuous visualization. Most recently, a retrospective analysis at St. George’s Healthcare NHS Trust, London, UK, demonstrated that 195 hTEE evaluations resulted in the change of therapy of 41 patients, which ultimately improved hemodynamic parameters in 80.5% of patients. RV failure was diagnosed in almost 70% of patients, of which hTEE had a direct therapeutic impact in 68%. The study is available online at the Journal of Cardiothoracic and Vascular Anesthesia . Dates and locations of these conferences: EAST Annual Scientific Assembly

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ImaCor

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ImaCor is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

ImaCor Patents

ImaCor has filed 13 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/7/2008

3/31/2015

Transiting exoplanets, Triangle geometry, Cygnus (constellation), Geometric centers, Triangle centers

Grant

Application Date

11/7/2008

Grant Date

3/31/2015

Title

Related Topics

Transiting exoplanets, Triangle geometry, Cygnus (constellation), Geometric centers, Triangle centers

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.